Veracyte | VCYT - Ativos

Preço das Ações
31.09
Mudança Diária
-0.26 -0.83%
Mensal
-4.22%
Anual
-2.23%
Q2 Previsão
30.24




Ativos Alterar Data
Agenus USD 226.8M 7.09M 2025-12
Agilent USD 12.81B 86M 2025-12
Anika Therapeutics USD 190.27M 833K 2025-12
Arrowhead Research USD 1.6B 218.89M 2025-12
Bruker USD 6.24B 193.5M 2025-12
Heron Therapeutics USD 255.88M 6.93M 2025-12
Illumina USD 6.64B 467M 2025-12
Intrexon USD 73.16M 77.88M 2024-06
Karyopharm Therapeutics USD 108.42M 12.18M 2025-12
Laboratory Of America USD 18.39B 131.1M 2025-12
Ligand Pharmaceuticals USD 1.56B 83.86M 2025-12
Myriad Genetics USD 706.6M 21.5M 2025-12
Rigel Pharmaceuticals USD 242.53M 35.8M 2025-09
Roche Holding CHF 100.7B 5.94B 2025-12
Sangamo BioSciences USD 97.56M 11.39M 2025-06
Siemens EUR 170.13B 3.93B 2025-12
Sonic Healthcare AUD 15.38B 550.57M 2024-12
Thermo Fisher Scientific USD 110.34B 7.32B 2025-12
Veracyte USD 1.41B 38.23M 2025-12
Waters USD 5.08B 221.41M 2025-12